Cystic Fibrosis

June 15, 2016June 15, 2016

TGV-inhalonix Presents Early Data on Drug to Treat Acute Lung Infections in CF Patients

Cystic Fibrosis, News

TGV-inhalonix, Inc., presented data on the drug candidate, Mul-1867, to treat antibiotic-resistant lung infections that is showing promise with the mixed bacterial and fungal infections found in cystic fibrosis (CF) patients. The presentation, from an animal ... Read more

June 15, 2016June 15, 2016

‘Up For Air’ Documentary Inspires Cystic Fibrosis Patients to Become Active Managing Their Health

Cystic Fibrosis, News

The Boomer Esiason Foundation (BEF) recently announced the release of a new documentary, “Up For Air,” premiering on June 20 at a private screening in New York City. BEF is a partnership of ... Read more

June 14, 2016June 14, 2016

New Data on Phase 3 Trial of Quinsair for Cystic Fibrosis Presented by Raptor at European CF Conference

Cystic Fibrosis, News

At the 39th European Cystic Fibrosis Conference, recently held in Basel, Switzerland, Raptor Pharmaceutical presented new data on its Phase 3 MPEX-209 clinical trial comparing Quinsair to inhaled tobramycin solution in patients ... Read more

June 14, 2016June 14, 2016

FDA-Approved Tromethamine May Be Effective in Treating Cystic Fibrosis Airway Disease, Study Shows

Cystic Fibrosis, News

Researchers at the University of Iowa Carver College of Medicine recently reported that the FDA-approved drug tromethamine may offer therapeutic benefits for patients with cystic fibrosis (CF). The findings were described in ... Read more

June 3, 2016June 6, 2016

Researchers Propose Repurposing Tromethamine as Potential CF Treatment

Cystic Fibrosis

This week, a team of interdisciplinary researchers led by Dr. Joseph Zabner, MD, of the University of Iowa’s Carver College of Medicine, published a study that provides evidence for the ... Read more

May 31, 2016May 31, 2016

‘CF Champions: Navigating the Journey, Together’ Launched by Walgreens

Cystic Fibrosis, News

During The Cystic Fibrosis Foundation’s National CF Awareness Month in May, Walgreens launched “CF Champions: Navigating the Journey, Together,” a campaign to support champion patients and caregivers affected by cystic fibrosis (CF). Cystic ... Read more

May 27, 2016May 27, 2016

Phase 2 Trial for Oral Cystic Fibrosis Treatment Gets Canada’s Green Light

Cystic Fibrosis, News

The Canadian biopharmeceutical corporation ProMetic Life Sciences has been authorized by Health Canada to begin a study on PBI-4050, its orally active anti-fibrotic investigational drug for the treatment of cystic fibrosis (CF). ... Read more

May 25, 2016May 25, 2016

Winners of Cystic Fibrosis STRIVE Awards Announced by PTC Therapeutics

Cystic Fibrosis, News

PTC Therapeutics recently announced the winners of the company’s Global Strategies to Realize Innovation, Vision and Empowerment (STRIVE) Awards Program, supporting nonprofits serving the cystic fibrosis (CF) community. The celebration overlaps ... Read more

May 24, 2016May 24, 2016

First Patient Dosed in Phase 2 Trial of Potential CF Treatment

Cystic Fibrosis, News

Nivalis Therapeutics, Inc., announced the first dosing of a cystic fibrosis (CF) patient enrolled in its second Phase 2 clinical trial evaluating the drug N91115, a stabilizer of the cystic fibrosis transmembrane conductance regulator ... Read more

May 23, 2016May 23, 2016

Discovered Molecule May Prolong Life of Cystic Fibrosis Patients, Researchers Say

Cystic Fibrosis, News

Scientists at Queen’s University Belfast discovered a new molecule with the potential to prolong the life of individuals with cystic fibrosis (CF). The molecule, QUB-TL1, may be a potential treatment option for ... Read more